Martín-Vallejo J, Molina-Bellido P, Laforga JB, Clemente-Pérez PA. Intestinal-type adenocarcinoma of the Bartholin gland: A case report and literature review.
Gynecol Oncol Rep 2021;
37:100836. [PMID:
34381862 PMCID:
PMC8334373 DOI:
10.1016/j.gore.2021.100836]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/25/2021] [Revised: 07/06/2021] [Accepted: 07/13/2021] [Indexed: 11/19/2022] Open
Abstract
This entity has pathological characteristics identical to mucinous colorectal carcinoma.
KRAS mutations are observed in approximately 40% of colorectal cancers.
The treatment and management may not differ from that of squamous cell carcinomas.
Purpose
To report a case of intestinal-type adenocarcinoma of the Bartholin gland treated successfully with surgery and to review the current literature.
Methods
We report the case of a 45-year-old white woman with intestinal-type adenocarcinoma of the Bartholin gland treated with wide local excision followed by bilateral inguinal femoral lymph node dissection without adjuvant therapy. We also review the literature on the treatment and management of this rare tumor. We searched Pubmed / MEDLINE databases for previous case reports or series using the keywords “Bartholin gland”, “adenocarcinoma” and “intestinal type”.
Results
We found 19 cases of intestinal-type adenocarcinoma of the Bartholin gland published up to November 2020. The treatments described varied from case to case.
Conclusion
Intestinal-type adenocarcinoma of the Bartholin gland has been treated and managed in the same way as squamous carcinoma. Treatment of these cancers is understudied and involves local resection with curative intent. More case reports are needed to determine the best treatment strategies.
Collapse